GLP-1 sellers that name their pharmacy
Only sellers that name their compounding pharmacy.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
10 sellers are partners on this board today, sorted first and labeled Partner — the one respect in which the ordering is commercial. Every other seller here is ranked purely on the published rubric, which cannot see commercial status either way.
The board at a glance
- 81 sellers are on the named-pharmacy GLP-1 board; 81 of them name their compounding pharmacy, and 6 require a consultation before any prescription.
- The lowest monthly figure published in this board's scope is $79/mo, for Semaglutide injection at Lean Meds; price is 6% of the order here, so it does not decide the rank.
What the evidence says, before the sellers
- SemaglutideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Every trial above used the approved product at labeled doses. None tested a compounded preparation, so their results describe Wegovy, not what a compounding pharmacy makes.
- TirzepatideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Both trials used the approved product. Neither tested a compounded preparation, so the numbers describe Zepbound, not a pharmacy's version of it.
The ranking
Each seller below prescribes semaglutide or tirzepatide and has a full review on this site; compare the first six below, then expand another group for more providers.
These service details do not establish treatment effectiveness. Read the assessments below for the evidence, pharmacy information and published prices.
- Rank01
OakPartner
Oak is first on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $200/mo
- Tirzepatide injection (compounded)from $250/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Oak is read on 70% of the rubric's weight: follow-up and state coverage are left out of its order, not counted against it.
- Rank02
EdenPartner
Eden is second on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $99/mo$198 a month with the required membership, our total
- Tirzepatide injection (compounded)from $199/mo$298 a month with the required membership, our total
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank03
YourEraPartner
YourEra is third on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Semaglutide injection (compounded)from $129 per 4 wks$140 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $199 per 4 wks$216 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board YourEra is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank04
Sprout HealthPartner
Sprout Health is fourth on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $299 per 4 wks$324 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $349 per 4 wks$378 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 44 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Sprout Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank05
PeterMDPartner
PeterMD is fifth on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $270/mo
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 42 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PeterMD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank06
EmbodyPartner
Embody is sixth on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)price not published
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Embody is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
Compare providers 7–18RxSpan MD, Bodybuilding Health+, Luvo Health, bmiMD, NowPatient, PlexusDx, Contour Health, Care Bare Rx, Try Ageless, Synergy Rx, Renlo Health, Levers Health
- Rank07
RxSpan MDPartner
RxSpan MD is seventh on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Semaglutide oral (compounded)from $249/mo
- Tirzepatide injection (compounded)from $329/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board RxSpan MD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank08
Bodybuilding Health+Partner
Bodybuilding Health+ is eighth on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $279/mo
- Tirzepatide injection (compounded)from $319/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Bodybuilding Health+ is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank09
Luvo HealthPartner
Luvo Health is ninth on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $209 per 4 wks$226 a calendar month, our arithmetic
- Semaglutide oral (compounded)from $259 per 4 wks$281 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $249 per 4 wks$270 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Luvo Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank10
bmiMDPartner
bmiMD is tenth on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $159 per 4 wks$172 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $249 per 4 wks$270 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank11
NowPatient
NowPatient is number 11 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (brand)from $215.98/mo$291 a month with the required shipping, our total
- Semaglutide oral (brand)from $99/mo$119 a month with the required shipping, our total
- Tirzepatide injection (brand)from $251.98/mo$327 a month with the required shipping, our total
- Prescriber and intake
- A consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board NowPatient is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank12
PlexusDx
PlexusDx is number 12 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $189/mo
- Tirzepatide injection (compounded)from $289/mo
- Semaglutide oral (compounded)from $289/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PlexusDx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank13
Contour Health
Contour Health is number 13 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Semaglutide injection (compounded)from $120 per 4 wks$130 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $200 per 4 wks$217 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Contour Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank14
Care Bare Rx
Care Bare Rx is number 14 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Care Bare Rx is read on 65% of the rubric's weight: dosing guidance and follow-up are left out of its order, not counted against it.
- Rank15
Try Ageless
Try Ageless is number 15 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $99/mo
- Semaglutide sublingual (compounded)from $199/mo
- Tirzepatide injection (compounded)from $169/mo
- Tirzepatide sublingual (compounded)from $249/mo
- Semaglutide oral (compounded)from $209/mo
- Tirzepatide oral (compounded)from $289/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Try Ageless is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank16
Synergy Rx
Synergy Rx is number 16 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide sublingual (compounded)price not published
- Tirzepatide injection (compounded)from $349/mo
- Tirzepatide sublingual (compounded)price not published
- Tirzepatide injection (brand)from $947/mo
- Semaglutide injection (brand)from $947/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Synergy Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank17
Renlo Health
Renlo Health is number 17 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $269/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank18
Levers Health
Levers Health is number 18 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price as the dose rises.
- What it prices here
- Semaglutide injection (compounded)from $247/mo
- Tirzepatide injection (compounded)from $296/mo
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Levers Health is read on 55% of the rubric's weight: prescriber and intake and state coverage are left out of its order, not counted against it.
Compare providers 19–30RxSaludable, Ivologist, Obu Health, Kova, EOS Health, Medro, Enhanced, REMEVi, Effecty, Hims, Trimi Health, Nova MD
- Rank19
RxSaludable
RxSaludable is number 19 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $179/mo
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board RxSaludable is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank20
Ivologist
Ivologist is number 20 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $149/mo
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists BPC-157, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Ivologist is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank21
Obu Health
Obu Health is number 21 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $190/mo
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Obu Health is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank22
Kova
Kova is number 22 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
Semaglutide and Tirzepatide are on Kova's own list with no price we hold.
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Kova is read on 65% of the rubric's weight: dosing guidance, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank23
EOS Health
EOS Health is number 23 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $169/mo
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 40 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board EOS Health is read on 50% of the rubric's weight: prescriber and intake and follow-up are left out of its order, not counted against it.
- Rank24
Medro
Medro is number 24 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Medro is read on 60% of the rubric's weight: dosing guidance, follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank25
Enhanced
Enhanced is number 25 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Semaglutide injection (compounded)from $89/mo
- Tirzepatide injection (compounded)from $129/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Enhanced is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank26
REMEVi
REMEVi is number 26 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199 per 4 wks$216 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $269 per 4 wks$291 a calendar month, our arithmetic
- Semaglutide oral (compounded)from $249 per 4 wks$269.75 a calendar month, our calendar-month conversion
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board REMEVi is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank27
Effecty
Effecty is number 27 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $170/mo
- Tirzepatide injection (compounded)from $235/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank28
Hims
Hims is number 28 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (brand)from $199/mo$348 a month with the required membership, our total
- Tirzepatide injection (brand)from $299/mo$448 a month with the required membership, our total
- Semaglutide oral (brand)from $149/mo$298 a month with the required membership, our total
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Hims is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank29
Trimi Health
Trimi Health is number 29 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $175/mo
- Tirzepatide injection (compounded)from $235/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Trimi Health is read on 75% of the rubric's weight: stays within legal scope is left out of its order, not counted against it.
- Rank30
Nova MD
Nova MD is number 30 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Semaglutide injection (compounded)from $175/mo
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Nova MD is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
Compare providers 31–42Fridays, Vyora Wellness, Avono Health, Get Thin MD, Zenbody, Trellis Vitality, MadeMed, Vytora Health, Revive Longevity, Woodwork, Lean Meds, ARSYNL Rx
- Rank31
Fridays
Fridays is number 31 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Tirzepatide injection (compounded)from $359/mo
- Semaglutide injection (brand)from $1,498/mo
- Tirzepatide injection (brand)from $1,828/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Fridays is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank32
Vyora Wellness
Vyora Wellness is number 32 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $299/mo
- Tirzepatide injection (compounded)from $399/mo
- Semaglutide oral (compounded)from $259/mo
- Tirzepatide oral (compounded)from $359/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Vyora Wellness is read on 60% of the rubric's weight: dosing guidance, follow-up and state coverage are left out of its order, not counted against it.
- Rank33
Avono Health
Avono Health is number 33 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $269/mo
- Tirzepatide injection (compounded)from $299/mo
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Avono Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank34
Get Thin MD
Get Thin MD is number 34 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank35
Zenbody
Zenbody is number 35 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)price not published
- Semaglutide oral (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Zenbody is read on 60% of the rubric's weight: stays within legal scope, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank36
Trellis Vitality
Trellis Vitality is number 36 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $150/mo
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Trellis Vitality is read on 75% of the rubric's weight: follow-up is left out of its order, not counted against it.
- Rank37
MadeMed
MadeMed is number 37 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)price not published
- Semaglutide sublingual (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Tirzepatide sublingual (compounded)price not published
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board MadeMed is read on 70% of the rubric's weight: state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank38
Vytora Health
Vytora Health is number 38 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Semaglutide injection (compounded)from $179/mo
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Vytora Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank39
Revive Longevity
Revive Longevity is number 39 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank40
Woodwork
Woodwork is number 40 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Woodwork is read on 65% of the rubric's weight: follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank41
Lean Meds
Lean Meds is number 41 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $79/mo
- Tirzepatide injection (compounded)from $129/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank42
ARSYNL Rx
ARSYNL Rx is number 42 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $229/mo
- Tirzepatide injection (compounded)from $269/mo
- Tirzepatide topical (compounded)from $269/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board ARSYNL Rx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
Compare providers 43–5450 Stars Health, RxION Health, Bloom MD, Nu Image Medical, PepHaūs, Welludr, Brello Health, Raeliva, Kongo, EdgeRx, PauseRX, Auren Rx
- Rank43
50 Stars Health
50 Stars Health is number 43 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $146/mo
- Tirzepatide injection (compounded)from $220/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board 50 Stars Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank44
RxION Health
RxION Health is number 44 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $299/mo
- Semaglutide injection (brand)from $1,499/mo
- Tirzepatide injection (brand)from $1,259/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board RxION Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank45
Bloom MD
Bloom MD is number 45 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $295/mo
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Bloom MD is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank46
Nu Image Medical
Nu Image Medical is number 46 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)price not published
- Semaglutide oral (compounded)from $269/mo
- Tirzepatide injection (compounded)from $289/mo
- Tirzepatide oral (compounded)from $314/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Nu Image Medical is read on 65% of the rubric's weight: follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank47
PepHaūs
PepHaūs is number 47 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $169/mo
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PepHaūs is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank48
Welludr
Welludr is number 48 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Semaglutide oral (compounded)price not published
- Tirzepatide oral (compounded)price not published
- Semaglutide injection (brand)from $1,399/mo
- Tirzepatide injection (brand)from $1,599/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Welludr is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank49
Brello Health
Brello Health is number 49 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 41 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Brello Health is read on 75% of the rubric's weight: price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank50
Raeliva
Raeliva is number 50 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $219/mo
- Semaglutide sublingual (compounded)from $260/mo
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide sublingual (compounded)from $359/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Raeliva is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank51
Kongo
Kongo is number 51 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Semaglutide injection (compounded)from $119/mo
- Tirzepatide injection (compounded)from $229/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank52
EdgeRx
EdgeRx is number 52 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $225/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- 46 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board EdgeRx is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank53
PauseRX
PauseRX is number 53 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board PauseRX is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank54
Auren Rx
Auren Rx is number 54 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Semaglutide injection (compounded)from $149/mo
- Tirzepatide injection (compounded)from $229/mo
- Prescriber and intake
- Names one prescribing physician
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Auren Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
Compare providers 55–66Jently, Whoosh Wellness, Invigor Medical, PreventiveMD, Pepti, Breeze Meds, Idgie Health, The Edit, ZYP Medical, Heros Health, PrescrYbe, HealthHub
- Rank55
Jently
Jently is number 55 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $259/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Jently is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank56
Whoosh Wellness
Whoosh Wellness is number 56 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark.
- What it prices here
- Semaglutide injection (compounded)from $169/mo
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)from $249/mo
- Prescriber and intake
- Names one prescribing physician
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Whoosh Wellness is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank57
Invigor Medical
Invigor Medical is number 57 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)from $350 per 4 wks$379 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Invigor Medical is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank58
PreventiveMD
PreventiveMD is number 58 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $119/mo
- Tirzepatide injection (compounded)from $139/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 36 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PreventiveMD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank59
Pepti
Pepti is number 59 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)from $99 per 4 wks$107 a calendar month, our arithmetic
- Semaglutide oral (compounded)price not published
- Tirzepatide injection (compounded)from $159 per 4 wks$172 a calendar month, our arithmetic
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Ipamorelin, Epitalon, TB-500, Retatrutide, KPV, Semax, which no pharmacy may lawfully compound
- State coverage
- 36 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank60
Breeze Meds
Breeze Meds is number 60 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Breeze Meds is read on 70% of the rubric's weight: follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank61
Idgie Health
Idgie Health is number 61 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $134/mo
- Semaglutide oral (compounded)from $287/mo
- Tirzepatide injection (compounded)from $179/mo
- Semaglutide injection (compounded)from $149/mo
- Tirzepatide injection (compounded)from $229/mo
- Tirzepatide oral (compounded)from $287/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
- Rank62
The Edit
The Edit is number 62 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $259/mo
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- A questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank63
ZYP Medical
ZYP Medical is number 63 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)from $299 per 4 wks$324 a calendar month, our arithmetic
- Tirzepatide sublingual (compounded)from $250/mo
- Prescriber and intake
- Names one prescribing physician; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, TB-500, KPV, 5-Amino-1MQ, which no pharmacy may lawfully compound
- State coverage
- 7 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
- Rank64
Heros Health
Heros Health is number 64 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, TB-500, Retatrutide, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Heros Health is read on 65% of the rubric's weight: dosing guidance, state coverage and price against the market are left out of its order, not counted against it.
- Rank65
PrescrYbe
PrescrYbe is number 65 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $249 per 4 wks$270 a calendar month, our arithmetic
- Semaglutide oral (compounded)from $279 per 4 wks$302 a calendar month, our arithmetic
- Tirzepatide injection (compounded)from $339 per 4 wks$367 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PrescrYbe is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank66
HealthHub
HealthHub is number 66 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Semaglutide sublingual (compounded)from $199/mo
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)from $199/mo
- Semaglutide oral (compounded)from $149/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board HealthHub is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
Compare providers 67–78Tyde Wellness, Nex Gen Health Rx, Alloy, AHBARx, Kin Meds, EllieMD, Found Youth, Brightmeds, Actin, Ascend Vitality, Joi + Blokes, Pomegranate Health
- Rank67
Tyde Wellness
Tyde Wellness is number 67 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank68
Nex Gen Health Rx
Nex Gen Health Rx is number 68 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $190/mo
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board Nex Gen Health Rx is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank69
Alloy
Alloy is number 69 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $70/mo$169 a month with the required membership, our total
- Semaglutide injection (brand)from $199/mo$448 a month with the required membership, our total
- Tirzepatide injection (compounded)from $100/mo$199 a month with the required membership, our total
- Tirzepatide injection (brand)from $299/mo$398 a month with the required membership, our total
- Semaglutide oral (brand)from $149/mo$248 a month with the required membership, our total
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Alloy is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank70
AHBARx
AHBARx is number 70 on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board AHBARx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank71
Kin Meds
Kin Meds is number 71 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (brand)price not published
- Tirzepatide injection (brand)price not published
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Kin Meds is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank72
EllieMD
EllieMD is number 72 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Epitalon, Thymosin alpha-1, Melanotan II, Semax, Selank, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board EllieMD is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank73
Found Youth
Found Youth is number 73 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $249/mo
- Semaglutide sublingual (compounded)from $229/mo
- Tirzepatide injection (compounded)from $329/mo
- Tirzepatide sublingual (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Found Youth is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank74
Brightmeds
Brightmeds is number 74 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $129/mo
- Tirzepatide injection (compounded)from $149/mo
- Tirzepatide injection (brand)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 47 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank75
Actin
Actin is number 75 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)from $198/mo
- Tirzepatide injection (compounded)from $269/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists CJC-1295, Ipamorelin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Actin is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank76
Ascend Vitality
Ascend Vitality is number 76 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)from $199/mo
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Ascend Vitality is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank77
Joi + Blokes
Joi + Blokes is number 77 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Joi + Blokes is read on 70% of the rubric's weight: state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank78
Pomegranate Health
Pomegranate Health is number 78 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $119/mo
- Tirzepatide injection (compounded)from $159/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Pomegranate Health is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
Compare providers 79–81TrueMe, He & She MD, FormBlends
- Rank79
TrueMe
TrueMe is number 79 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)price not published
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 6 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the named-pharmacy GLP-1 board TrueMe is read on 70% of the rubric's weight: follow-up and price against the market are left out of its order, not counted against it.
- Rank80
He & She MD
He & She MD is number 80 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)from $279/mo
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide oral (compounded)from $339/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board He & She MD is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank81
FormBlends
FormBlends is number 81 on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Semaglutide injection (compounded)from $165/mo
- Tirzepatide injection (compounded)from $214/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists MOTS-c, BPC-157, CJC-1295, Ipamorelin, Epitalon, DSIP, TB-500, Oxytocin, KPV, AOD-9604, Semax, Selank, LL-37, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board FormBlends is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
What the order on this board weighs
On the named-pharmacy GLP-1 board 8 of the rubric's 9 marks apply, rescaled to share the whole order between them: prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%. What each mark reads
- 29%
- Prescriber and intake
- 18%
- Pharmacy named
- 12%
- Dosing guidance
- 12%
- Follow-up
- 12%
- Stays within legal scope
- 6%
- State coverage
- 6%
- Price against the market
- 6%
- Price as the dose rises
Whether a seller pays us is not one of the 8 marks on the named-pharmacy GLP-1 board, and the rubric cannot read it.
GLP-1 sellers that name their pharmacy
Frequently asked questions
- How is the named-pharmacy GLP-1 board ordered?
- The 10 partners sort first and are labeled; after that the rubric decides. The rubric reads each seller on semaglutide and tirzepatide, and here prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%.
- Do you earn a commission from the sellers on the named-pharmacy GLP-1 board?
- On part of it. 10 sellers are partners on the named-pharmacy GLP-1 board, labeled Partner where they appear; the rest of the links pay us nothing.
- Which marks are not recorded on the named-pharmacy GLP-1 board?
- Not recorded: follow-up and state coverage for Oak, state coverage for YourEra, price as the dose rises for Sprout Health, price as the dose rises for PeterMD, dosing guidance and price as the dose rises for Embody, price as the dose rises for RxSpan MD, state coverage and price as the dose rises for Bodybuilding Health+, state coverage for Luvo Health, stays within legal scope, state coverage and price as the dose rises for NowPatient, price as the dose rises for PlexusDx, state coverage for Contour Health, dosing guidance and follow-up for Care Bare Rx, state coverage and price as the dose rises for Try Ageless, price as the dose rises for Synergy Rx, prescriber and intake and state coverage for Levers Health, state coverage for RxSaludable, price as the dose rises for Ivologist, dosing guidance and state coverage for Obu Health, dosing guidance, price against the market and price as the dose rises for Kova, prescriber and intake and follow-up for EOS Health, dosing guidance, follow-up and price as the dose rises for Medro, dosing guidance, state coverage and price as the dose rises for Enhanced, price as the dose rises for REMEVi, stays within legal scope, state coverage and price as the dose rises for Hims, stays within legal scope for Trimi Health, dosing guidance and state coverage for Nova MD, dosing guidance, state coverage and price as the dose rises for Fridays, dosing guidance, follow-up and state coverage for Vyora Wellness, state coverage for Avono Health, stays within legal scope, state coverage, price against the market and price as the dose rises for Zenbody, follow-up for Trellis Vitality, state coverage, price against the market and price as the dose rises for MadeMed, price as the dose rises for Vytora Health, follow-up, state coverage and price as the dose rises for Woodwork, state coverage and price as the dose rises for ARSYNL Rx, state coverage for 50 Stars Health, state coverage for RxION Health, state coverage and price as the dose rises for Bloom MD, follow-up, state coverage and price as the dose rises for Nu Image Medical, price as the dose rises for PepHaūs, state coverage and price as the dose rises for Welludr, price against the market and price as the dose rises for Brello Health, state coverage for Raeliva, dosing guidance and price as the dose rises for EdgeRx, state coverage for PauseRX, price as the dose rises for Auren Rx, state coverage and price as the dose rises for Jently, state coverage and price as the dose rises for Whoosh Wellness, state coverage and price as the dose rises for Invigor Medical, price as the dose rises for PreventiveMD, follow-up and price as the dose rises for Breeze Meds, dosing guidance, state coverage and price against the market for Heros Health, stays within legal scope, state coverage and price as the dose rises for PrescrYbe, dosing guidance, state coverage and price as the dose rises for HealthHub, state coverage for Nex Gen Health Rx, stays within legal scope, state coverage and price as the dose rises for Alloy, state coverage and price as the dose rises for AHBARx, state coverage and price as the dose rises for Kin Meds, dosing guidance, state coverage, price against the market and price as the dose rises for EllieMD, state coverage and price as the dose rises for Found Youth, state coverage and price as the dose rises for Actin, state coverage and price as the dose rises for Ascend Vitality, state coverage, price against the market and price as the dose rises for Joi + Blokes, dosing guidance and state coverage for Pomegranate Health, follow-up and price against the market for TrueMe, dosing guidance and price as the dose rises for He & She MD and dosing guidance, state coverage and price as the dose rises for FormBlends. Each is left out of that seller's order on this board, because our review of its pages found no answer, and the seller's other marks carry its place instead.
- Which sellers of semaglutide and tirzepatide are not on this board?
- 261 more sellers on our roster publish a price for semaglutide and tirzepatide and are not ranked on the named-pharmacy GLP-1 board until we publish a review of each one.